Pongwut Danchaivijitr Selected Research

Weight Loss (Weight Reduction)

3/2022

Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pongwut Danchaivijitr Research Topics

Disease

6	Neoplasms (Cancer) 10/2022 - 02/2016
3	Nasopharyngeal Carcinoma 02/2024 - 06/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2021
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 07/2017
2	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2023
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022 - 06/2020
2	Vomiting 11/2020 - 01/2017
2	Nausea 11/2020 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 02/2016
1	Kidney Diseases (Kidney Disease) 02/2023
1	Mucositis 02/2023
1	Thrombocytopenia (Thrombopenia) 02/2023
1	Hemorrhage 10/2022
1	Venous Thromboembolism 10/2022
1	Urogenital Neoplasms 10/2022
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 03/2022
1	Weight Loss (Weight Reduction) 03/2022
1	Hypertension (High Blood Pressure) 09/2021
1	Adenocarcinoma 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Anemia 07/2017
1	Pain (Aches) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2011

Drug/Important Bio-Agent (IBA)

3	Gefitinib (Iressa)FDA Link 12/2023 - 10/2023
3	lazertinibIBA 12/2023 - 10/2023
2	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 06/2020
2	Dalteparin (Dalteparin Sodium)FDA Link 10/2022 - 07/2017
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2022 - 07/2017
2	pazopanib FDA Link 11/2021 - 09/2021
2	Ondansetron (Zofran)FDA LinkGeneric 11/2020 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 03/2011
1	SteroidsIBA 12/2023
1	Carboplatin (JM8)FDA LinkGeneric 02/2023
1	CreatinineIBA 02/2023
1	AnticoagulantsIBA 10/2022
1	edoxabanIBA 10/2022
1	apixabanIBA 10/2022
1	RivaroxabanIBA 10/2022
1	atezolizumabIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	nintedanibIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	PlatinumIBA 01/2021
1	Aprepitant (Emend)FDA Link 11/2020
1	Olanzapine (Zyprexa)FDA Link 11/2020
1	Sunitinib (Sutent)FDA Link 07/2017
1	RadiumIBA 01/2017
1	Radium-223IBA 01/2017
1	enzalutamideIBA 01/2017
1	abirateroneIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Alkaline PhosphataseIBA 01/2017
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 02/2016
1	Immunoglobulin G (IgG)IBA 03/2011
1	Complement System Proteins (Complement)IBA 03/2011
1	Bortezomib (Velcade)FDA Link 03/2011

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 02/2024 - 01/2017
4	Chemoradiotherapy 02/2024 - 06/2020
3	Therapeutics 10/2022 - 01/2017
1	Adjuvant Chemotherapy 02/2024
1	Induction Chemotherapy 02/2024
1	Radiotherapy 03/2022
1	Gastrostomy 03/2022
1	Immunotherapy 01/2022
1	Castration 01/2017